Calamos Advisors LLC Raises Position in Cigna Group $CI

Posted by Geri Gentry on Jul 15th, 2026

Calamos Advisors LLC boosted its holdings in shares of Cigna Group (NYSE:CI – Free Report) by 33.1% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm owned 63,696 shares of the health services provider’s stock after buying an additional 15,825 shares during the period. Calamos Advisors LLC’s holdings in Cigna Group were worth $16,991,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Empirical Financial Services LLC d.b.a. Empirical Wealth Management grew its holdings in shares of Cigna Group by 56.0% during the first quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 2,945 shares of the health services provider’s stock worth $786,000 after purchasing an additional 1,057 shares in the last quarter. Bleakley Financial Group LLC increased its position in shares of Cigna Group by 12.8% in the first quarter. Bleakley Financial Group LLC now owns 15,305 shares of the health services provider’s stock worth $4,083,000 after purchasing an additional 1,735 shares during the last quarter. Principal Financial Group Inc. raised its stake in Cigna Group by 1.9% in the first quarter. Principal Financial Group Inc. now owns 310,580 shares of the health services provider’s stock valued at $82,847,000 after purchasing an additional 5,844 shares in the last quarter. Citizens National Bank Trust Department raised its stake in Cigna Group by 4.6% in the first quarter. Citizens National Bank Trust Department now owns 979 shares of the health services provider’s stock valued at $261,000 after purchasing an additional 43 shares in the last quarter. Finally, Chicago Partners Investment Group LLC lifted its position in Cigna Group by 61.3% during the first quarter. Chicago Partners Investment Group LLC now owns 7,453 shares of the health services provider’s stock valued at $2,047,000 after purchasing an additional 2,831 shares during the last quarter. 86.99% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Cigna Group

In other Cigna Group news, CAO Jamie G. Kates sold 899 shares of the business’s stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $298.61, for a total value of $268,450.39. Following the transaction, the chief accounting officer owned 2,368 shares in the company, valued at approximately $707,108.48. The trade was a 27.52% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO David Cordani sold 201,878 shares of the stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the sale, the chief executive officer owned 34,337 shares of the company’s stock, valued at approximately $10,054,560.34. This represents a 85.46% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.60% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have recently commented on CI shares. Morgan Stanley increased their price target on shares of Cigna Group from $355.00 to $361.00 and gave the stock an “overweight” rating in a report on Wednesday, May 20th. Barclays downgraded shares of Cigna Group from an “overweight” rating to an “equal weight” rating and dropped their price objective for the stock from $310.00 to $304.00 in a report on Tuesday, May 26th. Cantor Fitzgerald increased their target price on Cigna Group from $325.00 to $340.00 and gave the company an “overweight” rating in a research note on Friday, May 1st. Guggenheim increased their target price on Cigna Group from $334.00 to $338.00 and gave the company a “buy” rating in a research note on Monday, May 4th. Finally, Sanford C. Bernstein raised their price target on Cigna Group from $371.00 to $381.00 and gave the company an “outperform” rating in a research report on Thursday, July 9th. One analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Cigna Group has an average rating of “Moderate Buy” and a consensus price target of $338.80.

Read Our Latest Stock Report on Cigna Group

Cigna Group Stock Performance

NYSE CI opened at $303.44 on Wednesday. The company has a 50-day simple moving average of $286.50 and a two-hundred day simple moving average of $280.18. Cigna Group has a 12-month low of $239.51 and a 12-month high of $315.47. The firm has a market cap of $80.27 billion, a price-to-earnings ratio of 12.86, a PEG ratio of 1.17 and a beta of 0.29. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.69.

Cigna Group (NYSE:CI – Get Free Report) last released its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 EPS for the quarter, topping the consensus estimate of $7.60 by $0.19. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The firm had revenue of $68.52 billion for the quarter, compared to the consensus estimate of $66.29 billion. During the same quarter in the previous year, the business earned $6.74 earnings per share. The company’s quarterly revenue was up 4.6% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, equities analysts forecast that Cigna Group will post 30.39 EPS for the current year.

Cigna Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th were given a $1.56 dividend. The ex-dividend date was Thursday, June 4th. This represents a $6.24 annualized dividend and a yield of 2.1%. Cigna Group’s payout ratio is presently 26.45%.

Cigna Group Profile

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.